Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIIB | AZN | AMGN | GILD | BMY |
| Company | Biogen Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 194.02 | 188.47 | 340.75 | 127.96 | 57.69 |
| High | 195.98 | 189.65 | 348.94 | 132.21 | 60.56 |
| Low | 190.36 | 187.62 | 340.05 | 127.96 | 57.39 |
| Latest | 190.86 | 189.14 | 347.98 | 131.76 | 59.81 |
| Change | -3.52 | +3.94 | +9.96 | +2.92 | +2.22 |
| % Change | -1.81% | +2.13% | +2.95% | +2.27% | +3.85% |
| Volume | 242,833 | 575,496 | 677,007 | 1,201,624 | 6,289,060 |
| 20-Day Average Volume | 1,289,681 | 1,931,234 | 2,288,543 | 5,024,236 | 8,661,118 |
| Previous Close | 194.38 | 185.20 | 338.02 | 128.84 | 57.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 181.28 | 197.77 | 347.05 | 136.03 | 58.80 |
| 20-Day Raw Stochastic | 82.19% | 28.90% | 57.69% | 28.51% | 88.19% |
| 20-Day Relative Strength | 55.41 | 43.90 | 48.43 | 41.85 | 54.31 |
| Weighted Alpha | +52.84 | +27.72 | +22.67 | +22.76 | +25.30 |
| Today's Opinion | 72% Buy | 40% Buy | 24% Buy | 8% Buy | 72% Buy |
| Previous Opinion | 72% Buy | 40% Buy | 8% Buy | 8% Buy | 40% Buy |
| Last Month's Opinion | 64% Buy | 72% Buy | 40% Buy | 40% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.72% since 04/23/26 | -1.65% since 04/23/26 | -0.04% since 04/23/26 | -1.22% since 04/23/26 | +1.96% since 04/23/26 |
| Low | 179.15 on 04/27/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.28 on 04/29/26 |
| High | 195.98 on 04/30/26 | 190.59 on 04/27/26 | 348.53 on 04/30/26 | 132.32 on 04/24/26 | 60.55 on 04/30/26 |
| 1-Month | |||||
| %Chg | +1.89% since 03/30/26 | -2.46% since 03/30/26 | -0.15% since 03/30/26 | -3.18% since 03/30/26 | +0.75% since 03/30/26 |
| Low | 168.64 on 04/06/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 57.22 on 04/15/26 |
| High | 195.98 on 04/30/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +6.24% since 01/30/26 | +1.93% since 01/30/26 | +1.93% since 01/30/26 | -7.00% since 01/30/26 | +9.32% since 01/30/26 |
| Low | 168.64 on 04/06/26 | 181.73 on 04/29/26 | 333.55 on 04/29/26 | 127.64 on 04/27/26 | 54.96 on 02/02/26 |
| High | 202.41 on 02/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +27.74% since 10/30/25 | +14.84% since 10/30/25 | +19.35% since 10/30/25 | +11.46% since 10/30/25 | +31.91% since 10/30/25 |
| Low | 146.52 on 10/31/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 45.20 on 10/31/25 |
| High | 202.41 on 02/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 28,527,016 | 287,228,128 | 182,424,320 | 159,919,040 | 117,583,520 |
| Shares Outstanding, K | 146,759 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 9,890,600,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | 1,292,900,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 2,279,400,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -48,900,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.16 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.57 on 04/29/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Earnings Date | 04/29/26 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 11.99 | 20.38 | 15.54 | 15.86 | 9.47 |